NCT00323180|WithdrawnDMC
Study Stopped
PI left institution and no subjects enrolled and this is not a clinical trial.
Loading search results
Sponsor study identifier
observational
0
1 country
1
Study Start
August 2005
Actual (reported)Primary Completion
August 2005
Actual (reported)Study Completion
August 2005
Actual (reported)This study is looking at biomarkers in prostate cancer.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
August 2005
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 2005
Actual (reported)August 2005
Actual (reported)August 2005
Actual (reported)May 5, 2006
Actual (reported)May 9, 2006
Actual (reported)Patients with prostate cancer
Contact the study team to confirm eligibility.
University of New Mexico
Albuquerque, New Mexico, 87131, United States
Marco Bisoffi
University of New Mexico
0 participants (actual enrollment reported by the registry).
First Submitted
May 5, 2006
First Posted
May 9, 2006
Study Start
August 2005
Actual (reported)Primary Completion
Fulvestrant in Treating Patients With Advanced Prostate Cancer
Prostatic Acid Phosphatase (PAP) Vaccine in Patients With Prostate Cancer
August 2005
Actual (reported)Study Completion
August 2005
Actual (reported)Last Updated
January 11, 2024
Record last verified: 2024-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: